Results 21 to 30 of about 9,630 (208)

High Precision Use of Botulinum Toxin Type A (BONT-A) in Aesthetics Based on Muscle Atrophy, Is Muscular Architecture Reprogramming a Possibility? A Systematic Review of Literature on Muscle Atrophy after BoNT-A Injections

Toxins, 2022
Improvements in Botulinum toxin type-A (BoNT-A) aesthetic treatments have been jeopardized by the simplistic statement: “BoNT-A treats wrinkles”. BoNT-A monotherapy relating to wrinkles is, at least, questionable.
Alexander D. Nassif, Ricardo F. Boggio, Sheila Espicalsky, Gladstone E. L. Faria   +3 more
doaj   +1 more source

Personality Disorders among Individuals Seeking Cosmetic Botulinum Toxin Type A (BoNTA) Injection, a Cross-Sectional Study

Eurasian Journal of Medicine, 2019
Objective: Body dysmorphic disorder, narcissistic personality disorder, and histrionic personality disorders are the most frequent personality disorders in patients seeking cosmetic interventions.
Alireza Mohebbipour Loron, Azra Ghaffari, Negin Poursafargholi   +2 more
doaj   +1 more source

Real-World Dosing of OnabotulinumtoxinA and IncobotulinumtoxinA for Cervical Dystonia and Blepharospasm: Results from TRUDOSE and TRUDOSE II

Toxins, 2021
The real-world use of onabotulinumtoxinA and incobotulinumtoxinA for cervical dystonia and blepharospasm treatment was assessed in two separate retrospective studies using identical protocols (TRUDOSE and TRUDOSE II). The studies were conducted in Mexico,
Ruth Kent, Adrian Robertson, Sandra Quiñones Aguilar, Charalampos Tzoulis, John Maltman   +4 more
doaj   +1 more source

Dosage of botulinum toxin in patients undergoing treatment for hemifacial spasm: is there modification during follow-up?

Arquivos de Neuro-Psiquiatria
Background The movement disorder known as hemifacial spasm is characterized by involuntary contractions of the muscles that are innervated by the facial nerve. The treatment of choice for this condition is botulinum toxin injections.
Fátima de Menezes Dantas, Felipe Olobardi Freire, Agábio Diógenes Pessoa Neto, Clécio de Oliveira Godeiro Júnior, Rodrigo Alencar e Silva   +4 more
doaj   +1 more source

Uses of Botulinum Toxin in Headache and Facial Pain Disorders: An Update

Toxins
Botulinum toxin is a neurotoxin that is used in the treatments for several medical conditions, such as dystonia, spasticity, hemifacial spasm, overactive bladder, and hyperhidrosis.
Pedro Augusto Sampaio Rocha-Filho, Moises Dominguez, Christopher L. Robinson, Sait Ashina   +3 more
doaj   +1 more source

Genetically Confirmed Schwartz–Jampel Syndrome: An Ultra-Rare Case of Congenital Myotonia with Osteochondrodysplasia from India

International Journal of Medical Students
Background: Schwartz–Jampel syndrome is a rare autosomal recessive disorder caused by mutations in the HSPG2 gene, leading to perlecan deficiency. Perlecan is a heparan sulfate proteoglycan critical for cartilage integrity, basement membrane stability ...
Nandita Jali, Suvarna Magar, Tanya Trikha, Varsha Vaidya, Viranchi Vaidya   +4 more
doaj   +1 more source

Clinical Recovery and Circulating Botulinum Toxin Type F in Adult Patient

Emerging Infectious Diseases, 2009
A 56-year-old woman in Helena, Montana, USA, who showed clinical signs of paralysis, received antitoxins to botulinum toxins A, B, and E within 24 hours; nevertheless, symptoms progressed to complete quadriplegia. On day 8, she began moving spontaneously,
Jeremy Sobel, Tracy Dill, Christina L. Kirkpatrick, Laurel Riek, Patrick Luedtke, Todd A. Damrow   +5 more
doaj   +1 more source

Hazard analysis and possibilities for preventing botulism originating from meat products [PDF]

Veterinarski Glasnik, 2008
The paper presents the more important data on the bacteria Clostridium botulinum, the appearance of botulism, hazard analysis and the possibilities for preventing botulism.
Vasilev Dragan, Vuković Ilija
doaj   +1 more source

Botulinum toxin type B micromechanosensor [PDF]

Proceedings of the National Academy of Sciences, 2003
Botulinum neurotoxin (BoNT) types A, B, E, and F are toxic to humans; early and rapid detection is essential for adequate medical treatment. Presently available tests for detection of BoNTs, although sensitive, require hours to days. We report a BoNT-B sensor whose properties allow detection of BoNT-B within minutes.
W, Liu, Vedrana, Montana, Edwin R, Chapman, U, Mohideen, Vladimir, Parpura   +4 more
openaire   +2 more sources

Histological and immunohistochemical findings of the action of botulinum toxin in salivary gland: systematic review

Brazilian Journal of Biology
The treatment of sialorrhea is necessary for the constant risks posed by hypersalivation. A new therapeutic option comes up with the application of botulinum toxin in salivary glands.
J. B. Oliveira, J. Evêncio-Neto, L. Baratella-Evêncio   +2 more
doaj   +1 more source